vimarsana.com
  1. Home
  2. Live Updates
  3. International Spinal Cord Injury Pain Basic Data - Breaking News

International Spinal Cord Injury Pain Basic Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury

The DOSED Clinical Study Will Evaluate a Novel Delivery Device in Subacute and Chronic Spinal Cord Injury Patients .

United statesBrianm culleyCalifornia institute for regenerative medicine under propositionInternational spinal cord injury pain questionnaireCalifornia institute for regenerative medicineRoche groupDrug administrationExchange commissionCalifornia stem cell agencyInternational spinal cord injury pain basic dataLineage cell therapeutics incLineage cell therapeuticsInvestigational new drugOligodendrocyte progenitor cellsSpinal cord injuryNovel device

Lineage Announces Submission of OPC1 Investigational New Drug Amendment for Treatment of Chronic and Subacute Spinal Cord Injury

Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today that the Company has submitted an.

United statesBrianm culleyExchange commissionCalifornia institute for regenerative medicineLineage cell therapeutics incCalifornia institute for regenerative medicine under propositionCalifornia stem cell agencyRoche groupDrug administrationInternational spinal cord injury pain basic dataInternational spinal cord injury pain questionnaireLineage cell therapeuticsInvestigational new drugOligodendrocyte progenitor cellsSpinal cord injuryNovel device

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.